Skip to content
healthcare.dev

CYCLOSET

NDC 73515-123, bromocriptine mesylate, tablet, from Avvisto Therapeutics LLC.

Product NDC
73515-123
Status
Listed
Labeler
Avvisto Therapeutics LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020866
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73515-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BROMOCRIPTINE MESYLATE.8 mg/1

Pharmacologic classes

Ergolines [CS]; Ergot Derivative [EPC]

Package NDCNDC-11Package
73515-123-217351501232121 TABLET in 1 BOTTLE (73515-123-21)
73515-123-3073515012330200 TABLET in 1 BOTTLE (73515-123-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20
  • NADAC price for package 73515012330

    GET /v1/drugs/nadac/73515012330

Use it

Look up 73515-123 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73515-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73515-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.